Works matching IS 15228517 AND DT 2011 AND VI 13 AND IP 5
Results: 18
Editorial Board.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. NP, doi. 10.1093/neuonc/nor061
- Publication type:
- Article
Contents Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. NP, doi. 10.1093/neuonc/nor063
- Publication type:
- Article
Late relapse in primary central nervous system lymphoma: clonal persistence†.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 525, doi. 10.1093/neuonc/nor014
- By:
- Publication type:
- Article
Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 536, doi. 10.1093/neuonc/nor015
- By:
- Publication type:
- Article
Society news.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 563, doi. 10.1093/neuonc/nor043
- Publication type:
- Article
Response to MC Chamberlain: Convection-enhanced delivery of transforming growth factor-β2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to W Wick and M Weller: Trabedersen to target transforming ...
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 561, doi. 10.1093/neuonc/nor047
- By:
- Publication type:
- Article
Pretreatment neuropsychological deficits in children with brain tumors.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 517, doi. 10.1093/neuonc/nor013
- By:
- Publication type:
- Article
Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 487, doi. 10.1093/neuonc/nor010
- By:
- Publication type:
- Article
Subscription Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. NP, doi. 10.1093/neuonc/nor062
- Publication type:
- Article
Cover Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. NP, doi. 10.1093/neuonc/nor060
- Publication type:
- Article
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 530, doi. 10.1093/neuonc/nor044
- By:
- Publication type:
- Article
Glycogen synthase kinase 3β inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 459, doi. 10.1093/neuonc/nor016
- By:
- Publication type:
- Article
N-methylpurine DNA glycosylase and DNA polymerase β modulate BER inhibitor potentiation of glioma cells to temozolomide.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 471, doi. 10.1093/neuonc/nor011
- By:
- Publication type:
- Article
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 509, doi. 10.1093/neuonc/nor017
- By:
- Publication type:
- Article
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 500, doi. 10.1093/neuonc/nor022
- By:
- Publication type:
- Article
Convection-enhanced delivery of a transforming growth factor-β2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142).
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 558, doi. 10.1093/neuonc/nor048
- By:
- Publication type:
- Article
Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 546
- By:
- Publication type:
- Article
Trabedersen to target transforming growth factor-β: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132–142).
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 5, p. 559, doi. 10.1093/neuonc/nor046
- By:
- Publication type:
- Article